Risk related to spread of new SARS-CoV-2 variants of concern
ECDC presents the latest available information on the recent emergence of two variants of potential concern discovered in the United Kingdom and another variant identified in South Africa.
Sequence data will become increasingly important as SARS-CoV-2 vaccines and antivirals become available. ECDC's technical note aims to provide guidelines to laboratories and relevant stakeholders, addressing the most used sequencing technologies and their applications, and proposes a central standardisation process to analyse and report the findings of SARS-CoV-2 genetic characterisations.
